fda glp-1 compounding enforcement news Fmr. Commissioner weighs in on Medicare's involvement in prices FDA Escalates Enforcement Against Compounded

Digital weight loss company Noom has entered the evolving GLP-1 medication landscape with the launch of its Noom Microdose GLP-1Rx Program, offering members personalized microdoses of GLP-1 medications combined with behavioral coaching and clinical support

SMI strategies consider briefer stepwise surgical and medical treatments that can be deployed serially and/or concomitantly

For anyone looking into these medical treatments, choosing between a daily tablet and a weekly under-the-skin injection is a big decision

GLP-1 agonists have demonstrated safety and efficacy in clinical trials for weight loss, but individual safety depends on medical history, dosing protocol, and ongoing provider oversight

This gives practitioners and patients more choice to support their health goals, whether theyre just getting started or looking to maintain their progress

We discussed GLP-1 agonists and their potential role for Lipedema patients